DRD2 and trichotillomania: Given the role of D2 dopamine receptors in mediating response inhibition in the striatum (Ghahremani et al., 2012), and beneficial effects seen in trichotillomania with olanzapine, the current results may hint at why only certain medications appear to have efficacy in treating this neglected disorder.